IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

NEXTBio Capital Management LP

Portfolio Profile

CIK: 0002038158 | AUSTIN, TX

Investment Profile

Style

Core

Turnover

Medium

Orientation

Concentrated trader
$217.4M
AUM
22
Positions
77.7%
Top 10 Conc.
100%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Protagonist Therapeutics Inc(PTGX)219,333$26.9M12.37%
2Shattuck Labs Inc(STTK)3,727,348$25.9M11.90%
3Compass Pathways PLC(CMPS)1,775,759$25.1M11.56%
4Structure Therapeutics Inc(GPCR)312,496$16.8M7.71%
5VOR Biopharma Inc(VOR)889,164$16.4M7.53%

Sector Allocation

Latest filing, equity positions only

Healthcare98.28% · $213.7M
Unclassified1.72% · $3.7M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare98.15%98.28%+0.13%
Unclassified1.85%1.72%-0.13%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$170.5M | 23 pos.
$215.4M | 24 pos.
$217.4M | 22 pos.
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

3
New
5
6
Rhythm Pharmaceuticals Inc(RYTM)
131,758
$14.6M
6.73%
7Palvella Therapeutics Inc NE(PVLA)89,909$13.7M6.32%
8Xenon Pharmaceuticals Inc(XENE)183,225$11.1M5.09%
9Zenas Biopharma Inc(ZBIO)426,736$10.8M4.98%
10Oric Pharmaceuticals Inc(ORIC)706,124$7.6M3.52%
Cap SizePrev %Curr %Change
Small Cap49.73%57.18%+7.45%
Mid Cap47.13%40.47%-6.66%
Unclassified1.85%1.72%-0.13%
Micro Cap0.5%0.63%+0.13%
Large Cap0.79%0%-0.79%
Closed
7
Increased
5
Decreased
7
Unchanged